Skip to main content
Recall Canary
Diovan (valsartan) 160 mg Tablets
← Back to all recalls
DRUG RECALLMODERATE

Diovan (valsartan) 160 mg Tablets

Novartis recalls Diovan (valsartan) 160 mg tablets due to failed dissolution specs.

What to do

Stop taking the recalled Diovan tablets and contact your healthcare provider or pharmacist for guidance. You may also contact Novartis for further instructions and possible replacement or refund.

Recalled
Listed
Updated
Recall No.
D-0746-2026
Agency
FDA
Firm
Novartis Pharmaceuticals Corporation
Recall ID
99552
Status
ONGOING

Why it was recalled

Novartis Pharmaceuticals Corporation is recalling Diovan (valsartan) 160 mg tablets in 90-count bottles because they failed dissolution specifications, which may affect how the drug is absorbed. Consumers should stop taking the affected product and consult their healthcare provider for guidance.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Diovan (valsartan)

Lot code
AV5913C, 2027
Strength
160 mg
NDC / UPC
NDC 0078-0359-34

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Dissolution Failure recalls

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification